Mirae Asset Global Etfs Holdings Ltd. Chroma Dex Corp. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Chroma Dex Corp. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 29,327 shares of CDXC stock, worth $180,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,327
Previous 28,079
4.44%
Holding current value
$180,067
Previous $149,000
35.57%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CDXC
# of Institutions
149Shares Held
24.4MCall Options Held
190KPut Options Held
14.1K-
Vanguard Group Inc Valley Forge, PA3.54MShares$21.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.99MShares$12.2 Million6.26% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.28MShares$7.88 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.18MShares$7.24 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...